Stagni G, Francisci D, Pegiati R, Baldelli F
Istituto di Clinica delle Malattie Infettive, Università degli Studi di Perugia.
Boll Ist Sieroter Milan. 1987;66(6):453-5.
The Authors studied anti-HTLV III antibodies prevalence in jailed people of Perugia jail. Out of 207 healthy subjects, 10.6% were positive to anti-HTLV III. Prevalence in drug abusers (27.5%) was not apparently different from that observed in a control population of addicts who lived in the community. Prevalence in prisoners who were not intravenous drug abusers (2.2%) was higher, when compared with prevalence in general, "not at risk", population. This result can be explained by the exposition to different risk factors, some of which could depend on prisoner status.
作者研究了佩鲁贾监狱在押人员中抗人类嗜T淋巴细胞病毒III型（HTLV III）抗体的流行情况。在207名健康受试者中，10.6%的人抗HTLV III呈阳性。吸毒者中的流行率（27.5%）与生活在社区中的吸毒成瘾者对照组中观察到的流行率无明显差异。与一般“无风险”人群相比，非静脉吸毒囚犯中的流行率（2.2%）更高。这一结果可以通过接触不同的风险因素来解释，其中一些因素可能取决于囚犯身份。
